AP NEWS

Global Diabetes Insulin Delivery Pens Market Research Report 2018 - ResearchAndMarkets.com

September 21, 2018

DUBLIN--(BUSINESS WIRE)--Sep 21, 2018--The “Diabetes Insulin Delivery Pens Market Research Report 2018” report has been added to ResearchAndMarkets.com’s offering.

Diabetes Insulin Delivery Pen market will surpass US$ 14.4 Billion by 2025

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user-friendly design, rising popularity among consumers, help avoid over/under-dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices

Diabetes Insulin Delivery Pens Market Research Report 2018 presents an in-depth assessment of the diabetes insulin delivery pen market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for diabetes insulin delivery pen market. The report includes historical data from 2011 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, insulin pen volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. It also provides an all-round analysis of an overall number of patients with diabetes and insulin users. A comprehensive analysis has been done on market share of diabetes insulin delivery pen segment and countries-based market. The report also explores detailed description of growth drivers and inhibitors of the diabetes insulin delivery pens market.

The superior geographic segments are identified in the report, which also studies the prospects showcased by the emerging markets. It covers the United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil from 2011 to 2017 and forecasts to 2025.

The report concludes with the profiles of major players in the diabetes insulin delivery pens market. The key market players are evaluated on various parameters such as company overview, product portfolios and the recent development of the diabetes insulin delivery pens market.

Market segment by Type, the product can be split into

Reusable Insulin Pens Disposable Insulin Pens

The Latest Industry Data Included in this Report:

Diabetes Population in 10 major markets(10MM) 2011-2025 Insulin Users Insights in 10 major markets(10MM) 2011 - 2025 Total Diabetes Insulin Delivery Pen Users (Volume), 2011 - 2025 Reusable (Cartridge) Insulin Delivery Pen Users (Volume), 2011 - 2025 Prefilled (Disposable) Insulin Delivery Pen Users (Volume), 2011 - 2025 Total Diabetes Insulin Delivery Pen Market Size & Analysis (Value) 2011-2025 Reusable (Cartridge) Insulin Delivery Pen Market (Value), 2011-2025 Prefilled (Disposable) Insulin Delivery Pen Market (Value), 2011-2025 Total Diabetes Insulin Delivery Pen Market Share, By Users (%), 2011 - 2025 Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%) 2011 - 2025 Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2011 - 2025 Total Diabetes Insulin Delivery Pen Market Share (%), 2011 - 2025 Reusable (Cartridge) Insulin Delivery Pen Market Share (%), 2011 - 2025 Prefilled (Disposable) Insulin Delivery Pen Market Share (%), 2011 - 2025 Diabetes Insulin Delivery Pen Market, By Geography (Volume and Value), 2011 - 2025 Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market A Comprehensive List of Key Market Players Along with the Analysis of their Current Product Portfolios and Recent Development

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Novo Nordisk Eli Lilly Sanofi Owen Mumford Ypsomed Biocon Ltd For more information about this report visit https://www.researchandmarkets.com/research/dlcfx8/global_diabetes?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180921005315/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diabetes Devices,Endocrine and Metabolic Disorders Drugs,Endocrinology

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/21/2018 09:50 AM/DISC: 09/21/2018 09:50 AM

http://www.businesswire.com/news/home/20180921005315/en

AP RADIO
Update hourly